Logo image of RERE

ATRENEW INC (RERE) Stock Fundamental Analysis

NYSE:RERE - New York Stock Exchange, Inc. - US00138L1089 - ADR

2.655  -0.05 (-1.67%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to RERE. RERE was compared to 119 industry peers in the Specialty Retail industry. While RERE has a great health rating, there are worries on its profitability. While showing a medium growth rate, RERE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RERE had negative earnings in the past year.
In the past 5 years RERE always reported negative net income.
RERE had negative operating cash flow in 4 of the past 5 years.
RERE Yearly Net Income VS EBIT VS OCF VS FCFRERE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -1B -2B

1.2 Ratios

RERE has a Return On Assets of -2.84%. This is in the lower half of the industry: RERE underperforms 63.79% of its industry peers.
The Return On Equity of RERE (-4.21%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.84%
ROE -4.21%
ROIC N/A
ROA(3y)-23.13%
ROA(5y)-27.29%
ROE(3y)-29.48%
ROE(5y)-36.06%
ROIC(3y)N/A
ROIC(5y)N/A
RERE Yearly ROA, ROE, ROICRERE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

The Gross Margin of RERE (11.59%) is worse than 91.38% of its industry peers.
RERE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for RERE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.06%
GM growth 5Y28.93%
RERE Yearly Profit, Operating, Gross MarginsRERE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30 -40

More info and screens

7

2. Health

2.1 Basic Checks

RERE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RERE has less shares outstanding
Compared to 5 years ago, RERE has more shares outstanding
The debt/assets ratio for RERE is higher compared to a year ago.
RERE Yearly Shares OutstandingRERE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
RERE Yearly Total Debt VS Total AssetsRERE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

There is no outstanding debt for RERE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.53%
RERE Yearly LT Debt VS Equity VS FCFRERE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.68 indicates that RERE has no problem at all paying its short term obligations.
RERE's Current ratio of 2.68 is amongst the best of the industry. RERE outperforms 89.66% of its industry peers.
RERE has a Quick Ratio of 2.07. This indicates that RERE is financially healthy and has no problem in meeting its short term obligations.
RERE has a Quick ratio of 2.07. This is amongst the best in the industry. RERE outperforms 89.66% of its industry peers.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.07
RERE Yearly Current Assets VS Current LiabilitesRERE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

More info and screens

6

3. Growth

3.1 Past

RERE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.67%, which is quite impressive.
Looking at the last year, RERE shows a very strong growth in Revenue. The Revenue has grown by 31.37%.
The Revenue has been growing by 31.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)93.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.13%
Revenue 1Y (TTM)31.37%
Revenue growth 3Y38.71%
Revenue growth 5Y31.79%
Sales Q2Q%29.93%

3.2 Future

The Earnings Per Share is expected to decrease by -34.53% on average over the next years. This is quite bad
Based on estimates for the next years, RERE will show a very strong growth in Revenue. The Revenue will grow by 24.56% on average per year.
EPS Next Y-76.62%
EPS Next 2Y-34.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.07%
Revenue Next 2Y24.56%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RERE Yearly Revenue VS EstimatesRERE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
RERE Yearly EPS VS EstimatesRERE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RERE. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 105.34 indicates a quite expensive valuation of RERE.
Based on the Price/Forward Earnings ratio, RERE is valued a bit more expensive than the industry average as 67.24% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of RERE to the average of the S&P500 Index (24.44), we can say RERE is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 105.34
RERE Price Earnings VS Forward Price EarningsRERE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RERE Per share dataRERE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as RERE's earnings are expected to decrease with -34.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-34.53%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RERE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATRENEW INC

NYSE:RERE (1/22/2025, 11:49:01 AM)

2.655

-0.05 (-1.67%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-20 2024-11-20/bmo
Earnings (Next)N/A N/A
Inst Owners26.37%
Inst Owner Change0.15%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap588.62M
Analysts85.71
Price Target3.21 (20.9%)
Short Float %0.2%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-89.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 105.34
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)0.03
Fwd EY0.95%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.03
BVpS2.3
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.84%
ROE -4.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.59%
FCFM N/A
ROA(3y)-23.13%
ROA(5y)-27.29%
ROE(3y)-29.48%
ROE(5y)-36.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.06%
GM growth 5Y28.93%
F-ScoreN/A
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.68
Quick Ratio 2.07
Altman-Z N/A
F-ScoreN/A
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.13%
EPS Next Y-76.62%
EPS Next 2Y-34.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.37%
Revenue growth 3Y38.71%
Revenue growth 5Y31.79%
Sales Q2Q%29.93%
Revenue Next Year24.07%
Revenue Next 2Y24.56%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A